SIX1 and PAI-1 emerge as therapeutic targets in systemic sclerosis

Nature Reviews Rheumatology 2026

View at publisher

Authors: Sarah Onuora

DOI: 10.1038/s41584-026-01367-5

Cited by: 0

References: 2

Fields of Study & Subjects

Systemic Sclerosis and Related Diseases Dupuytren's Contracture and Treatments Connective tissue disorders research

References 2